WAY-262611 is a compound that interferes with the Wnt signaling pathway, which plays a key role in regulating cell proliferation, migration, and differentiation.
Molecular Weight
318.42
Molecular Formula
C20H22N4
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
WAY-262611 is a Wnt inhibitor, examined for its potential therapeutical impact on bone density by modulating Wnt signaling.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
